Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keith (now rebranded as Kitsa) is a healthcare technology company that provides an AI-powered platform for clinical trial recruitment and patient engagement. The platform utilizes artificial intelligence and natural language processing to analyze electronic health records (EHRs) and match patients to clinical trials based on complex inclusion and exclusion criteria. By automating the screening process and providing a marketplace for sponsors and research sites, Keith aims to accelerate trial enrollment, reduce screening failures, and improve diversity in clinical research. The company's technology transforms unstructured medical data into actionable insights, helping research sites maximize revenue and sponsors complete trials more efficiently.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Keith.